Last reviewed · How we verify

NCT04462107

Longitudinal Study Evaluating Recovery After Scheduled Cesarean Delivery

Completed Last updated 28 January 2026
What this trial tests

trial testing Surveys in Cesarean Section in 66 participants. Completed in 1 November 2021.

Timeline
1 February 2021
Primary endpoint
1 November 2021
1 November 2021

Quick facts

Lead sponsorMayo Clinic
StatusCompleted
Study typeOBSERVATIONAL
Enrollment66
Start date1 February 2021
Primary completion1 November 2021
Estimated completion1 November 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

Adults 18 to 40, female only, with Cesarean Section. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to describe how patients recover after scheduled C-section for the first 3 months.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Profiling Postpartum Recovery After Scheduled Cesarean Delivery With Neuraxial Anesthesia: A Longitudinal Cohort Study.
    Sharpe EE, Sviggum HP, Carvalho B, Guo N, et al · · 2025 · cited 1× · PMID 40184308 · DOI 10.1213/ane.0000000000007476

Verify or expand the search:

Other trials of Surveys

Trials testing the same drug.

Other recruiting trials for Cesarean Section

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04462107.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing